They also break down or corrupt the cells of our intestinal wall, causing raised cortisol levels and, over time, Leaky Gut, which then allows them and other toxins to enter our blood stream
Quick Answer: GLP-1 receptor agonists are diabetes and obesity medications currently being investigated in clinical trials for potential neuroprotective effects in Parkinson's disease, but they are not licensed or recommended for this condition
Briefly, cells were kept in growth medium consisting of DMEM with 10% FBS, 10 mM HEPES, 2 mM L-glutamine, 100 U/ml penicillin, 100 mg/ml streptomycin (all from Thermo Fisher Scientific Waltham, MA, United States), and 2.5 ng/ml hFGF-2 (all Sigma St
Specific disc levels and peptide considerations Not all disc herniations are identical, and the specific level affected can influence protocol decisions